跳至主要内容
临床试验/NL-OMON54000
NL-OMON54000已完成3 期

Effectiveness of analgesic ear drops as add-on treatment to oral analgesics in children with acute otitis media: a pragmatic randomised controlled trial - analgesic ear drops for children with acute otitis media (OPTIMA)

niversitair Medisch Centrum Utrecht0 个研究点目标入组 300 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
0 至 11(—)

入选标准

  • - Age 1 to 6 years
  • - Parent-reported ear pain in 24 hours prior to enrolment
  • - GP-diagnosis of (uni- or bilateral) AOM

排除标准

  • - with (suspected) tympanic membrane perforation or ventilation tubes
  • - with ear wax obscuring visualisation of the tympanic membrane
  • - who are systemically very unwell or require hospital admission (e.g. child
  • has signs and symptoms of serious illness and/or complications such as
  • mastoiditis/meningitis).
  • - who are at high risk of serious complications including children with known
  • immunodeficiency other than partial IgA or IgG2 deficiencies, craniofacial
  • malformation including cleft palate, Down syndrome and previous ear surgery
  • (with the exception of ventilation tubes in the past).
  • - who have a known allergy or sensitivity to study medication or similar
  • substances (e.g. other amide-type anaesthetics, bupivacaine, mepivacaine,
  • prilocaine)
  • - who have taken part in any research involving medicines within the last 90
  • days, or any other AOM-related research within the last 30 days.
  • - who suffer from chronic recurrent pain of another origin than the ear.
  • - who have participated in this trial during prior AOM episode.

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验